Tag Archives: MorphoSys

Evotec Establishes Integrated Communications and Investor Relations Leadership Role

(IN BRIEF) Evotec SE has created a new Executive Vice President role that combines Global Communications and Investor Relations as part of a broader effort to strengthen strategic clarity and stakeholder engagement. Dr. Sarah Fakih has been appointed to lead … Read the full press release

MorphoSys Finalizes Delisting from Frankfurt and Nasdaq Markets Following Novartis Acquisition

(IN BRIEF) MorphoSys AG has completed its voluntary delisting from the Frankfurt Stock Exchange and Nasdaq Global Market following its acquisition by Novartis. The delisting agreement, announced on June 20, 2024, and the subsequent delisting purchase offer by Novartis were … Read the full press release